{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Although reasonable incidences of many of these side effects can be \" softly \" deduced from current reports dealing with unfractionated heparin , at present the incidences of these side effects with newer low molecular weight heparins appear to be much less common .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| unfractionated heparin |\n\nThe only disease entity mentioned in the paragraph is \"unfractionated heparin,\" which is a type of anticoagulant medication."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| unfractionated heparin |\n\nThe only disease entity mentioned in the paragraph is \"unfractionated heparin,\" which is a type of anticoagulant medication. The term \"side effects\" is not a disease entity, but rather a description of the adverse consequences of a disease or medication. Therefore, it is not included in the table."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Although reasonable incidences of many of these side effects can be \" softly \" deduced from current reports dealing with unfractionated heparin , at present the incidences of these side effects with newer low molecular weight heparins appear to be much less common .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| unfractionated heparin |\n| low molecular weight heparins |\n\nIn this paragraph, the two chemical entities mentioned are \"unfractionated heparin\" and \"low molecular weight heparins.\" These are both types of heparin, which is a naturally occurring anticoagulant used in medical treatments. Unfractionated heparin is a full-length form of heparin, while low molecular weight heparins are smaller fragments of heparin with similar anticoagulant properties."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| unfractionated heparin |\n| low molecular weight heparins |\n\nIn this paragraph, the two chemical entities mentioned are \"unfractionated heparin\" and \"low molecular weight heparins.\" These are both types of heparin, which is a naturally occurring anticoagulant used in medical treatments. The word \"heparins\" in the plural form is used to refer to low molecular weight heparins, so it is not necessary to include it as a separate entity. The word \"softly\" is an adverb used to describe how the side effects can be deduced, and is not a chemical entity."}
  ]
}